Quteba Ebrahem

2.1k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Quteba Ebrahem is a scholar working on Molecular Biology, Hematology and Ophthalmology. According to data from OpenAlex, Quteba Ebrahem has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Hematology and 9 papers in Ophthalmology. Recurrent topics in Quteba Ebrahem's work include Acute Myeloid Leukemia Research (11 papers), Retinal Diseases and Treatments (8 papers) and Epigenetics and DNA Methylation (7 papers). Quteba Ebrahem is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Retinal Diseases and Treatments (8 papers) and Epigenetics and DNA Methylation (7 papers). Quteba Ebrahem collaborates with scholars based in United States, United Kingdom and China. Quteba Ebrahem's co-authors include Bela Anand‐Apte, Jian Qi, Gillian Murphy, Andrew H. Baker, Mark Bond, Nina Z. Moore, Lena Claesson‐Welsh, Jonathan E. Sears, Yogen Saunthararajah and Reda Z. Mahfouz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Quteba Ebrahem

30 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

2003 520 citations Jian Qi, Quteba Ebrahem et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Quteba Ebrahem United States	18	808	408	289	252	244	31	1.5k
Dorit Nahari United States	9	752 0.9×	295 0.7×	138 0.5×	85 0.3×	56 0.2×	9	1.4k
Douglas Armellino United States	15	1.3k 1.7×	401 1.0×	76 0.3×	444 1.8×	156 0.6×	18	2.3k
Tong Sun China	22	1.2k 1.5×	523 1.3×	76 0.3×	97 0.4×	166 0.7×	61	2.0k
E. Ioachim Greece	24	674 0.8×	317 0.8×	142 0.5×	269 1.1×	56 0.2×	79	1.7k
Amy E. Birsner United States	21	644 0.8×	187 0.5×	114 0.4×	149 0.6×	64 0.3×	34	1.2k
Karyn Bouhana United States	13	560 0.7×	295 0.7×	84 0.3×	107 0.4×	65 0.3×	26	946
Donna Hylton United States	8	1.2k 1.5×	356 0.9×	631 2.2×	543 2.2×	57 0.2×	12	2.3k
Abdullah Mahmood Ali United States	20	1.5k 1.8×	309 0.8×	70 0.2×	56 0.2×	319 1.3×	60	2.0k
O. Roche France	26	714 0.9×	312 0.8×	140 0.5×	85 0.3×	125 0.5×	85	1.9k
Markus Thomas Germany	19	1.4k 1.7×	409 1.0×	99 0.3×	576 2.3×	68 0.3×	28	2.1k

Countries citing papers authored by Quteba Ebrahem

Since Specialization

Citations

This map shows the geographic impact of Quteba Ebrahem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quteba Ebrahem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quteba Ebrahem more than expected).

Fields of papers citing papers by Quteba Ebrahem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quteba Ebrahem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quteba Ebrahem. The network helps show where Quteba Ebrahem may publish in the future.

Co-authorship network of co-authors of Quteba Ebrahem

This figure shows the co-authorship network connecting the top 25 collaborators of Quteba Ebrahem. A scholar is included among the top collaborators of Quteba Ebrahem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quteba Ebrahem. Quteba Ebrahem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Feng, Ye, Lan Li, Reda Z. Mahfouz, et al.. (2019). Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion. Scientific Reports. 9(1). 4558–4558. 9 indexed citations

2.

Ebrahem, Quteba, Reda Z. Mahfouz, Lisa Durkin, et al.. (2015). Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response. Blood. 126(23). 678–678. 6 indexed citations

3.

Gu, Xiaorong, Zhenbo Hu, Quteba Ebrahem, et al.. (2014). Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy. Journal of Biological Chemistry. 289(21). 14881–14895. 26 indexed citations

4.

Mahfouz, Reda Z., Ania Jankowska, Quteba Ebrahem, et al.. (2013). Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy. Clinical Cancer Research. 19(4). 938–948. 105 indexed citations

5.

Ng, Kwok Peng, Zhenbo Hu, Quteba Ebrahem, et al.. (2013). Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation. Oncogenesis. 2(11). e78–e78. 12 indexed citations

6.

Qi, Jian, Quteba Ebrahem, Alecia Cutler, et al.. (2013). Tissue Inhibitor of Metalloproteinases-3 Peptides Inhibit Angiogenesis and Choroidal Neovascularization in Mice. PLoS ONE. 8(3). e55667–e55667. 31 indexed citations

7.

Morais, Christudas, Quteba Ebrahem, Bela Anand‐Apte, & Marie‐Odile Parat. (2012). Altered Angiogenesis in Caveolin-1 Gene–Deficient Mice Is Restored by Ablation of Endothelial Nitric Oxide Synthase. American Journal Of Pathology. 180(4). 1702–1714. 30 indexed citations

8.

Ng, Kwok Peng, Quteba Ebrahem, Soledad Negrotto, et al.. (2011). p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia. 25(11). 1739–1750. 51 indexed citations

9.

Hu, Zhenbo, Soledad Negrotto, Xiaorong Gu, et al.. (2010). Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus. Molecular Cancer Therapeutics. 9(6). 1536–1543. 40 indexed citations

10.

Anand‐Apte, Bela, Quteba Ebrahem, Alecia Cutler, et al.. (2010). Betacellulin Induces Increased Retinal Vascular Permeability in Mice. PLoS ONE. 5(10). e13444–e13444. 25 indexed citations

11.

Keith, Patricia, Michiko Watanabe, Monica M. Montano, et al.. (2009). VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks. The Anatomical Record. 292(3). 320–332. 55 indexed citations

12.

Ebrahem, Quteba, Shyam S. Chaurasia, Amit Vasanji, et al.. (2009). Cross-Talk between Vascular Endothelial Growth Factor and Matrix Metalloproteinases in the Induction of Neovascularization in Vivo. American Journal Of Pathology. 176(1). 496–503. 96 indexed citations

13.

Keith, Patricia, Michiko Watanabe, Monica M. Montano, et al.. (2009). VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks. The Anatomical Record. 292(3). 3 indexed citations

14.

Anand‐Apte, Bela, Quteba Ebrahem, Alicia A. Cutler, Joe G. Hollyfield, & Judah Folkman. (2008). Betacellulin Induces Increased Retinal Vascular Permeability in Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 49(13). 3297–3297. 1 indexed citations

15.

Sears, Jonathan E., George Hoppe, Quteba Ebrahem, & Bela Anand‐Apte. (2008). Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Proceedings of the National Academy of Sciences. 105(50). 19898–19903. 94 indexed citations

16.

Renganathan, Kutralanathan, Quteba Ebrahem, Amit Vasanji, et al.. (2007). Carboxyethylpyrrole Adducts, Age-related Macular Degeneration and Neovascularization. Advances in experimental medicine and biology. 613. 261–267. 11 indexed citations

17.

Ebrahem, Quteba, Atsushi Minamoto, George Hoppe, Bela Anand‐Apte, & Jonathan E. Sears. (2006). Triamcinolone Acetonide Inhibits IL-6– and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF Receptors. Investigative Ophthalmology & Visual Science. 47(11). 4935–4935. 58 indexed citations

18.

Qi, Jian, Quteba Ebrahem, & Bela Anand‐Apte. (2003). Tissue Inhibitor of Metalloproteinases-3 and Sorsby Fundus Dystrophy. Advances in experimental medicine and biology. 533. 97–105. 6 indexed citations

19.

Qi, Jian, Quteba Ebrahem, Nina Z. Moore, et al.. (2003). A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nature Medicine. 9(4). 407–415. 520 indexed citations breakdown →

20.

Qi, Jian, Quteba Ebrahem, Karen Yeow, et al.. (2002). Expression of Sorsby's Fundus Dystrophy Mutations in Human Retinal Pigment Epithelial Cells Reduces Matrix Metalloproteinase Inhibition and May Promote Angiogenesis. Journal of Biological Chemistry. 277(16). 13394–13400. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact